US: Hospitals urge DOJ antitrust probe of Anthem-Cigna deal

Hospitals urged antitrust regulators this week to consider whether health insurer Anthem Inc.’s planned acquisition of rival Cigna Corp. would boost health care costs.

In a letter to the US Department of Justice, the hospital industry’s largest lobbying group said combining the No. 2 and No. 5 health insurers threatens to reduce competition in 817 geographic markets serving 45 million consumers.

In many of those markets, the American Hospital Association said, there are no strong competitors to buy assets that Anthem or Cigna might want to sell to pass muster with federal authorities. State insurance regulators will also look at the deal.

On July 24, Anthem announced plans to buy Cigna for $47 billion, the second major health insurer deal announced this summer. Aetna Inc. on July 3 inked an agreement with Humana Inc. The deals will reduce the number of national insurers to three from five.

Anthem and Cigna have said they expect the deal to pass antitrust scrutiny and that they have considered where asset sales might be needed.

The hospital association said in the letter dated Aug. 5 that it doubted Anthem and Cigna would find a suitable buyer for assets that provide insurance plans to millions of customers, also known as covered lives. Merging companies often will sell assets to a competitor if they believe it will help a larger deal pass regulatory scrutiny.

“In the 817 at-risk markets, over half the lives that need to be divested reside across 368 (metro regions) and rural counties with no divestiture possibility,” the group wrote.

Anthem and Cigna may need to divest from 2.9 million to 3.7 million covered lives in the commercial business to preserve competition in those markets, it said, and 1.7 million to 2 million of those are in markets with no potential acquirer. The analysis was based on the Herfindahl-Hirschman Index that measures market concentration.

Full content: The Fiscal Times

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.